This inventor holds 1 USPTO granted patent. Top assignee: Pacira Cryotech, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Jared Ham in Cryogenic Therapy
Introduction
Jared Ham is an accomplished inventor based in Severn, MA (US). He has made significant contributions to the field of cryogenic therapy, focusing on methods that enhance patient care. His innovative approach has led to the development of a unique patent that addresses critical medical needs.
Latest Patents
Jared Ham holds a patent for "Cryogenic therapy systems and methods." This patent describes a method of interrupting sympathetic stimulation to the cardiovascular system of a patient in need. The process involves navigating a probe of a hand-held cryogenic therapy apparatus to a stellate ganglion or an autonomic tissue area peripheral to the stellate ganglion. The probe includes a needle designed to create a cooling zone for focused cryogenic therapy. By aligning the needle with desired nerves, the method produces a cooling zone that provides cryogenic therapy at a temperature sufficient to cause axonotmesis of the nerves.
Career Highlights
Jared Ham is associated with Pacira Cryotech, Inc., where he continues to innovate in the field of cryogenic therapy. His work has the potential to transform treatment options for patients suffering from various cardiovascular conditions. With 1 patent to his name, he is recognized for his contributions to medical technology.
Collaborations
Some of Jared's notable coworkers include John Spranger and Roy Winston. Their collaboration fosters an environment of innovation and shared expertise, enhancing the development of advanced therapeutic solutions.
Conclusion
Jared Ham's work in cryogenic therapy exemplifies the impact of innovative thinking in medicine. His patent and ongoing contributions are paving the way for improved patient outcomes in cardiovascular treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile